NCT05905926Phase 3Enrolling by invitation

Safety Study of Tenapanor for the Treatment of Pediatric Patients (6 to Less Than 18 Years Old) With IBS-C

Study sponsor: Ardelyx

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2031-07Estimated
Enrollment · participants150Estimated
Source updated2026-06-04Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.

Explore older trial changes

Upgrade to Pro to see the full available history for this trial.

Upgrade to Pro Illustrative preview